Lorcaserin Extended-Release Tablets and Reteplase, recombinant Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Reteplase, recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: reteplase
Brand name: Retavase, Retavase Half-Kit
Synonyms: Reteplase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Retin A
- Lorcaserin Extended-Release Tablets-Retin-A (Tretinoin Cream)
- Lorcaserin Extended-Release Tablets-Retin-A (Tretinoin Gel)
- Lorcaserin Extended-Release Tablets-Retin-A Cream, Gel, Liquid
- Lorcaserin Extended-Release Tablets-Retin-A Micro
- Lorcaserin Extended-Release Tablets-Retin-A Micro Topical
- Reteplase, recombinant Intravenous-Lorcaserin Hydrochloride
- Reteplase, recombinant Intravenous-Lorcaserin Tablets
- Reteplase, recombinant Intravenous-Lorcet
- Reteplase, recombinant Intravenous-Lorcet Plus
- Reteplase, recombinant Intravenous-Lorcet Tablets
- Reteplase, recombinant Intravenous-Lorlatinib